Dodla Dairy Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 8:38 pm

Competitors of Dodla Dairy Ltd

All Competitor Stocks of Dodla Dairy Ltd

Quarterly Result

Last Updated: August 19, 2025, 7:55 pm

Below is a detailed analysis of the quarterly data for Dodla Dairy Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,007.00 Cr.. The value appears strong and on an upward trend. It has increased from 910.00 Cr. (Mar 2025) to 1,007.00 Cr., marking an increase of 97.00 Cr..
• For Expenses, as of Jun 2025, the value is 924.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 826.00 Cr. (Mar 2025) to 924.00 Cr., marking an increase of 98.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 84.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 8.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 9.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 81.00 Cr., marking a decrease of 9.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Mar 2025) to 22.00%, marking a decrease of 3.00%.
• For Net Profit, as of Jun 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 5.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.42. The value appears to be declining and may need further review. It has decreased from 11.27 (Mar 2025) to 10.42, marking a decrease of 0.85.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:08 pm

Growth

Last Updated: September 5, 2025, 3:16 pm

Balance Sheet

Last Updated: July 25, 2025, 1:25 pm

Below is a detailed analysis of the balance sheet data for Dodla Dairy Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2024) to 60.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,346.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,079.00 Cr. (Mar 2024) to 1,346.00 Cr., marking an increase of 267.00 Cr..
• For Borrowings, as of Mar 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 46.00 Cr. (Mar 2024) to 42.00 Cr., marking a decrease of 4.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 282.00 Cr.. The value appears to be improving (decreasing). It has decreased from 293.00 Cr. (Mar 2024) to 282.00 Cr., marking a decrease of 11.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,731.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,478.00 Cr. (Mar 2024) to 1,731.00 Cr., marking an increase of 253.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 750.00 Cr.. The value appears strong and on an upward trend. It has increased from 713.00 Cr. (Mar 2024) to 750.00 Cr., marking an increase of 37.00 Cr..
• For CWIP, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Investments, as of Mar 2025, the value is 644.00 Cr.. The value appears strong and on an upward trend. It has increased from 196.00 Cr. (Mar 2024) to 644.00 Cr., marking an increase of 448.00 Cr..
• For Other Assets, as of Mar 2025, the value is 324.00 Cr.. The value appears to be declining and may need further review. It has decreased from 556.00 Cr. (Mar 2024) to 324.00 Cr., marking a decrease of 232.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,731.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,478.00 Cr. (Mar 2024) to 1,731.00 Cr., marking an increase of 253.00 Cr..

Notably, the Reserves (1,346.00 Cr.) exceed the Borrowings (42.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Dodla Dairy Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 43.27. This value is within the healthy range. It has increased from 28.03 (Mar 24) to 43.27, marking an increase of 15.24.
• For Diluted EPS (Rs.), as of Mar 25, the value is 43.27. This value is within the healthy range. It has increased from 27.75 (Mar 24) to 43.27, marking an increase of 15.52.
• For Cash EPS (Rs.), as of Mar 25, the value is 55.46. This value is within the healthy range. It has increased from 39.80 (Mar 24) to 55.46, marking an increase of 15.66.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 233.05. It has increased from 191.43 (Mar 24) to 233.05, marking an increase of 41.62.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 233.05. It has increased from 191.43 (Mar 24) to 233.05, marking an increase of 41.62.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 616.64. It has increased from 525.35 (Mar 24) to 616.64, marking an increase of 91.29.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 71.96. This value is within the healthy range. It has increased from 53.16 (Mar 24) to 71.96, marking an increase of 18.80.
• For PBIT / Share (Rs.), as of Mar 25, the value is 59.59. This value is within the healthy range. It has increased from 41.38 (Mar 24) to 59.59, marking an increase of 18.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 58.97. This value is within the healthy range. It has increased from 40.98 (Mar 24) to 58.97, marking an increase of 17.99.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 43.09. This value is within the healthy range. It has increased from 28.03 (Mar 24) to 43.09, marking an increase of 15.06.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 43.09. This value is within the healthy range. It has increased from 28.03 (Mar 24) to 43.09, marking an increase of 15.06.
• For PBDIT Margin (%), as of Mar 25, the value is 11.66. This value is within the healthy range. It has increased from 10.11 (Mar 24) to 11.66, marking an increase of 1.55.
• For PBIT Margin (%), as of Mar 25, the value is 9.66. This value is below the healthy minimum of 10. It has increased from 7.87 (Mar 24) to 9.66, marking an increase of 1.79.
• For PBT Margin (%), as of Mar 25, the value is 9.56. This value is below the healthy minimum of 10. It has increased from 7.80 (Mar 24) to 9.56, marking an increase of 1.76.
• For Net Profit Margin (%), as of Mar 25, the value is 6.98. This value is within the healthy range. It has increased from 5.33 (Mar 24) to 6.98, marking an increase of 1.65.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.98. This value is below the healthy minimum of 8. It has increased from 5.33 (Mar 24) to 6.98, marking an increase of 1.65.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 14.64 (Mar 24) to 18.48, marking an increase of 3.84.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.26. This value is within the healthy range. It has increased from 20.25 (Mar 24) to 24.26, marking an increase of 4.01.
• For Return On Assets (%), as of Mar 25, the value is 15.01. This value is within the healthy range. It has increased from 11.28 (Mar 24) to 15.01, marking an increase of 3.73.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.32. It has increased from 2.29 (Mar 24) to 2.32, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has increased from 2.70 (Mar 24) to 3.71, marking an increase of 1.01.
• For Quick Ratio (X), as of Mar 25, the value is 3.06. This value exceeds the healthy maximum of 2. It has increased from 1.22 (Mar 24) to 3.06, marking an increase of 1.84.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.96. This value exceeds the healthy maximum of 8. It has decreased from 10.14 (Mar 24) to 8.96, marking a decrease of 1.18.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.96. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 6.96, marking an increase of 6.96.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.40. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 5.40, marking an increase of 5.40.
• For Earning Retention Ratio (%), as of Mar 25, the value is 93.04. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 93.04, marking an increase of 93.04.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.60. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 94.60, marking an increase of 94.60.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 117.14. This value is within the healthy range. It has decreased from 131.78 (Mar 24) to 117.14, marking a decrease of 14.64.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 71.14. This value is within the healthy range. It has increased from 70.47 (Mar 24) to 71.14, marking an increase of 0.67.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,907.11. It has increased from 4,696.41 (Mar 24) to 6,907.11, marking an increase of 2,210.70.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from 1.50 (Mar 24) to 1.86, marking an increase of 0.36.
• For EV / EBITDA (X), as of Mar 25, the value is 15.91. This value exceeds the healthy maximum of 15. It has increased from 14.85 (Mar 24) to 15.91, marking an increase of 1.06.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has increased from 1.53 (Mar 24) to 1.88, marking an increase of 0.35.
• For Retention Ratios (%), as of Mar 25, the value is 93.03. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 93.03, marking an increase of 93.03.
• For Price / BV (X), as of Mar 25, the value is 4.96. This value exceeds the healthy maximum of 3. It has increased from 4.19 (Mar 24) to 4.96, marking an increase of 0.77.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has increased from 1.53 (Mar 24) to 1.88, marking an increase of 0.35.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness